Science and Technology Science and Technology
Wed, December 11, 2024
[ Wed, Dec 11th 2024 ] - The New Yorker
The Year Creators Took Over
[ Wed, Dec 11th 2024 ] - MSN
Top 5 ETF categories to watch in 2025
[ Wed, Dec 11th 2024 ] - THE WEEK
Inside Trump's billionaire Cabinet
[ Wed, Dec 11th 2024 ] - MSN
How will the 2030 World Cup work?
[ Wed, Dec 11th 2024 ] - MSN
The Best Socket Sets for Tested
[ Wed, Dec 11th 2024 ] - MSN
UFC Tampa media day live stream
[ Wed, Dec 11th 2024 ] - Food & Wine
Japanese Curry Chicken Pot Pie
[ Wed, Dec 11th 2024 ] - MSN
Extreme H gets FIA World Cup status

As Dr. Mark Dertzbaugh Retires, MRDC Honors His Thirty-Plus Years of Service


Published on 2024-12-11 12:02:28 - usace.army.mil
  Print publication without navigation

  • For Dr. Mark Dertzbaugh, who retired Tuesday as the Principal Assistant for Research and Technology at the Medical Research and

Dr. Mark Dertzbaugh, after over thirty years of service, was honored by the Medical Research and Development Command (MRDC) upon his retirement. His career began in 1989 at the Walter Reed Army Institute of Research, where he focused on bacterial pathogenesis and vaccine development. Throughout his tenure, Dertzbaugh made significant contributions to military medical research, particularly in the development of vaccines for biodefense. His work extended to leading research on vaccines for diseases like anthrax, plague, and tularemia, and he played a key role in the development of the FDA-approved anthrax vaccine, BioThrax. His leadership also saw advancements in the MRDC's strategic direction, enhancing its capabilities in infectious disease research and biodefense. Colleagues praised his dedication, scientific expertise, and his ability to foster collaboration across various scientific disciplines, leaving a lasting impact on military medical research.

Read the Full usace.army.mil Article at:
[ https://www.army.mil/article/281955/as_dr_mark_dertzbaugh_retires_mrdc_honors_his_thirty_plus_years_of_service ]